These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Estimation of kidneys and urinary bladder doses based on the region of interest in Mustapha FA; Bashah FAA; Yassin IM; Fathinul Fikri AS; Nordin AJ; Abdul Razak HR Quant Imaging Med Surg; 2017 Jun; 7(3):310-317. PubMed ID: 28811997 [TBL] [Abstract][Full Text] [Related]
24. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer. Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586 [TBL] [Abstract][Full Text] [Related]
25. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]
26. Estimation of Radiation Exposure to Workers During [ Al-Aamria M; Al-Balushia N; Bailey D J Med Imaging Radiat Sci; 2019 Dec; 50(4):565-570. PubMed ID: 31447232 [TBL] [Abstract][Full Text] [Related]
27. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273 [TBL] [Abstract][Full Text] [Related]
28. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Han A; Xue J; Hu M; Zheng J; Wang X Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050 [TBL] [Abstract][Full Text] [Related]
29. Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome). Ranade R; Kand P; Basu S Nucl Med Commun; 2015 Oct; 36(10):1014-20. PubMed ID: 26049373 [TBL] [Abstract][Full Text] [Related]
30. An Australian local diagnostic reference level for paediatric whole-body Alkhybari EM; McEntee MF; Willowson KP; Brennan PC; Kitsos T; Kench PL Br J Radiol; 2019 Apr; 92(1096):20180879. PubMed ID: 30653334 [TBL] [Abstract][Full Text] [Related]
31. Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG. Pencharz D; McMeekin H; Wagner T; Wickham F Nucl Med Commun; 2016 Aug; 37(8):860-4. PubMed ID: 27115065 [TBL] [Abstract][Full Text] [Related]
32. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results. Ozkan E; Aras G; Kucuk NO Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis. Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419 [TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues. Povoski SP; Murrey DA; Smith SM; Martin EW; Hall NC BMC Cancer; 2014 Jun; 14():453. PubMed ID: 24942656 [TBL] [Abstract][Full Text] [Related]
35. Whole-body MRI versus Wang D; Huo Y; Chen S; Wang H; Ding Y; Zhu X; Ma C Onco Targets Ther; 2018; 11():3597-3608. PubMed ID: 29950864 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185 [TBL] [Abstract][Full Text] [Related]
37. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. Leide-Svegborn S Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792 [TBL] [Abstract][Full Text] [Related]
38. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer. Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167 [TBL] [Abstract][Full Text] [Related]
39. Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience. Povoski SP; Hall NC; Murrey DA; Chow AZ; Gaglani JR; Bahnson EE; Mojzisik CM; Kuhrt MP; Hitchcock CL; Knopp MV; Martin EW World J Surg Oncol; 2011 Nov; 9():152. PubMed ID: 22112047 [TBL] [Abstract][Full Text] [Related]